Emricasan in Patients With NASH and F1-F3 Fibrosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Randomized, Placebo-Controlled Trial of Emricasan in Patients With NASH and F1-F3 Fibrosis
J. Hepatol. 2020 May 01;72(5)816-827, SA Harrison, Z Goodman, A Jabbar, R Vemulapalli, ZH Younes, B Freilich, MY Sheikh, JM Schattenberg, Z Kayali, A Zivony, A Sheikh, J Garcia-Samaniego, SK Satapathy, G Therapondos, E Mena, D Schuppan, J Robinson, JL Chan, DT Hagerty, AJ SanyalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.